BackNatco Pharma Q4 Results Live : profit rise by 40.07% YOY
Natco Pharma Q4 Results Live : Revenue increased by 18.98% YoY & profit increased by 40.07% YoY
PremiumNatco Pharma Q4 Results Live : Natco Pharma declared their Q4 results on 27 May, 2024. The topline increased by 18.98% & the profit increased by 40.07% YoY. Compared to the previous quarter, the revenue grew by 40.83% and the profit increased by 81.62%.
The Selling, general & administrative expenses rose by 16.9% q-o-q & increased by 19.85% Y-o-Y.
The operating income was up by 97.32% q-o-q & increased by 48.21% Y-o-Y.
The EPS is ₹21.56 for Q4, which increased by 42.79% Y-o-Y.
Natco Pharma has delivered 3% return in the last 1 week, 31.9% return in the last 6 months, and 26.87% YTD return.
Currently, Natco Pharma has a market cap of ₹18437.57 Cr and a 52wk high/low of ₹1108.35 & ₹615.5 respectively.
As of 28 May, 2024, out of 9 analysts covering the company, 1 analyst has given a Strong Sell rating, 1 analyst has given a Sell rating, 1 analyst has given a Hold rating, 4 analysts have given a Buy rating, and 2 analysts have given a Strong Buy rating.
The consensus recommendation as of 28 May, 2024, was to Buy.
| Period | Q4 | Q3 | Q-o-Q Growth | Q4 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 1068.3 | 758.6 | +40.83% | 897.9 | +18.98% |
| Selling/ General/ Admin Expenses Total | 142.5 | 121.9 | +16.9% | 118.9 | +19.85% |
| Depreciation/ Amortization | 55.5 | 44.2 | +25.57% | 41 | +35.37% |
| Total Operating Expense | 626.5 | 534.7 | +17.17% | 599.8 | +4.45% |
| Operating Income | 441.8 | 223.9 | +97.32% | 298.1 | +48.21% |
| Net Income Before Taxes | 477.6 | 256.3 | +86.34% | 324.4 | +47.23% |
| Net Income | 386.3 | 212.7 | +81.62% | 275.8 | +40.07% |
| Diluted Normalized EPS | 21.56 | 11.88 | +81.48% | 15.1 | +42.79% |
FAQs
Question : What is the Q4 profit/Loss as per company?
Ans : ₹386.3Cr
Question : What is Q4 revenue?
Ans : ₹1068.3Cr
Stay updated on quarterly results with our results calendar
You are on Mint! India's #1 news destination (Source: Press Gazette). To learn more about our business coverage and market insights Click Here!
